153 related articles for article (PubMed ID: 10981828)
1. Combined effect of rebamipide and ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.
Hayashi S; Sugiyama T; Yokota K; Isogai H; Isogai E; Shimomura H; Oguma K; Asaka M; Hirai Y
Microbiol Immunol; 2000; 44(7):557-62. PubMed ID: 10981828
[TBL] [Abstract][Full Text] [Related]
2. Effect of ecabet sodium on Helicobacter pylori adhesion to gastric epithelial cells.
Hayashi S; Sugiyama T; Yachi A; Yokota K; Hirai Y; Oguma K; Fujii N
J Gastroenterol; 1997 Oct; 32(5):593-7. PubMed ID: 9349983
[TBL] [Abstract][Full Text] [Related]
3. Effect of rebamipide, a novel antiulcer agent, on Helicobacter pylori adhesion to gastric epithelial cells.
Hayashi S; Sugiyama T; Amano K; Isogai H; Isogai E; Aihara M; Kikuchi M; Asaka M; Yokota K; Oguma K; Fujii N; Hirai Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):1895-9. PubMed ID: 9687380
[TBL] [Abstract][Full Text] [Related]
4. [The Efficacy of Rebamipide or Ecabet Sodium Supplementation for Helicobacter pylori Eradication Therapy Compared with Quadruple (Concomitant) Regimen].
Kim J; Kim K; Lee JS; Kim SY; Kim KO; Kim YJ; Kwon KA; Park DK; Chung JW
Korean J Gastroenterol; 2018 Apr; 71(4):204-212. PubMed ID: 29684969
[TBL] [Abstract][Full Text] [Related]
5. [Effect of antiulcer agents on the urea breath test--Comparison between rebamipide and ecabet sodium].
Inaba T; Mizuno M; Kawai K; Takaguchi K; Yoshida Y; Kita K; Okada H; Tsuji T
Nihon Shokakibyo Gakkai Zasshi; 2002 Jan; 99(1):27-33. PubMed ID: 11831005
[TBL] [Abstract][Full Text] [Related]
6. Ecabet sodium, a locally acting antiulcer drug, inhibits urease activity of Helicobacter pylori.
Ito Y; Shibata K; Hongo A; Kinoshita M
Eur J Pharmacol; 1998 Mar; 345(2):193-8. PubMed ID: 9600637
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Helicobacter pylori-induced nuclear factor-kappa B activation and interleukin-8 gene expression by ecabet sodium in gastric epithelial cells.
Kim JM; Kim JS; Jung HC; Oh YK; Kim N; Song IS
Helicobacter; 2003; 8(5):542-53. PubMed ID: 14536001
[TBL] [Abstract][Full Text] [Related]
8. Ecabet sodium eradicates Helicobacter pylori infection in gastric ulcer patients.
Shimoyama T; Fukuda Y; Fukuda S; Munakata A; Yoshida Y; Shimoyama T
J Gastroenterol; 1996 Nov; 31 Suppl 9():59-62. PubMed ID: 8959522
[TBL] [Abstract][Full Text] [Related]
9. Ecabet sodium inhibits the ability of Helicobacter pylori to induce neutrophil production of reactive oxygen species and interleukin-8.
Shimoyama T; Fukuda S; Liu Q; Nakaji S; Munakata A; Sugawara K
J Gastroenterol; 2001 Mar; 36(3):153-7. PubMed ID: 11291877
[TBL] [Abstract][Full Text] [Related]
10. Rebamipide prevents delay of acetic acid-induced gastric ulcer healing caused by Helicobacter pylori infection in Mongolian gerbils.
Watanabe T; Higuchi K; Hamaguchi M; Tanigawa T; Wada R; Tominaga K; Fujiwara Y; Arakawa T
Dig Dis Sci; 2002 Jul; 47(7):1582-9. PubMed ID: 12141820
[TBL] [Abstract][Full Text] [Related]
11. Bactericidal effect of ecabet sodium on clarithromycin- and metronidazole-resistant clinical isolates of Helicobacter pylori.
Shibata K; Kasuga O; Yasoshima A; Matsushita T; Kawakami Y
Jpn J Antibiot; 1997 Jun; 50(6):525-31. PubMed ID: 9258741
[TBL] [Abstract][Full Text] [Related]
12. The effect of rebamipide on Helicobacter pylori extract-mediated changes of gene expression in gastric epithelial cells.
Yoshida N; Ishikawa T; Ichiishi E; Yoshida Y; Hanashiro K; Kuchide M; Uchiyama K; Kokura S; Ichikawa H; Naito Y; Yamamura Y; Okanoue T; Yoshikawa T
Aliment Pharmacol Ther; 2003 Jul; 18 Suppl 1():63-75. PubMed ID: 12925142
[TBL] [Abstract][Full Text] [Related]
13. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants.
Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M
Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190
[TBL] [Abstract][Full Text] [Related]
14. Rebamipide inhibits ceramide-induced interleukin-8 production in Kato III human gastric cancer cells.
Masamune A; Yoshida M; Sakai Y; Shimosegawa T
J Pharmacol Exp Ther; 2001 Aug; 298(2):485-92. PubMed ID: 11454909
[TBL] [Abstract][Full Text] [Related]
15. Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Song KH; Lee YC; Fan DM; Ge ZZ; Ji F; Chen MH; Jung HC; Bo J; Lee SW; Kim JH
Digestion; 2011; 84(3):221-9. PubMed ID: 21757914
[TBL] [Abstract][Full Text] [Related]
16. Does the depth of gastric ulceration influence a modified dual therapy with amoxicillin and lansoprazole for Helicobacter pylori-associated gastric ulcer?
Okai T; Ohtsubo K; Sakai J; Watanabe H; Motoo Y; Kawashima A; Sawabu N
Can J Gastroenterol; 2000 Oct; 14(9):761-6. PubMed ID: 11064311
[TBL] [Abstract][Full Text] [Related]
17. Rebamipide abolishes Helicobacter pylori CagA-induced phospholipase D1 expression via inhibition of NFκB and suppresses invasion of gastric cancer cells.
Kang DW; Hwang WC; Park MH; Ko GH; Ha WS; Kim KS; Lee YC; Choi KY; Min DS
Oncogene; 2013 Jul; 32(30):3531-42. PubMed ID: 22890316
[TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of a new anti-ulcer agent, ecabet sodium, for the treatment of Helicobacter pylori infection.
Ohkusa T; Takashimizu I; Fujiki K; Araki A; Ariake K; Shimoi K; Honda K; Enomoto Y; Sakurazawa T; Horiuchi T; Suzuki S; Ishii K; Ishikura T
Aliment Pharmacol Ther; 1998 May; 12(5):457-61. PubMed ID: 9663726
[TBL] [Abstract][Full Text] [Related]
19. Effects of rebamipide in combination with lansoprazole and amoxicillin on Helicobacter pylori-infected gastric ulcer patients.
Kato M; Asaka M; Sugiyama T; Kudo M; Nishikawa K; Sukegawa M; Hokari K; Katagiri M; Sato F; Kagaya H; Takeda H
Dig Dis Sci; 1998 Sep; 43(9 Suppl):198S-202S. PubMed ID: 9753250
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of the use of rebamipide in the scheme of triple eradication therapy of Helicobacter pylori infection: a prospective randomized comparative study.
Andreev DN; Maev IV; Dicheva DT; Samsonov AA; Partzvania-Vinogradova EV
Ter Arkh; 2018 Aug; 90(8):27-32. PubMed ID: 30701936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
